Abstract
Neurodegenerative diseases represent one of the most important public health problems and concerns, as they are a growing cause of mortality and morbidity worldwide, particularly in the elderly. However, natural products have a significant function in the avoidance of disease by boosting health in humans as well as animals. These natural products have been scientifically acknowledged to have a range of biological characteristics like antioxidant, and anti-inflammatory actions. Both In vitro and in vivo studies have more recognized the convenience of natural products in different preclinical models of neurodegenerative disorders. Moreover, most NPs comprise phytoconstituents, including polyphenolic antioxidants; originate in herbs, fruits, nuts, vegetables, as well as, also in marine with freshwater flora. These phytoconstituents might actively repress neuro-degeneration and recover memory as like cognitive actions of the brain. Moreover, they are well recognized to participate in an essential position in the prevention of like treatment of different neurodegenerative diseases, like Alzheimer’s disease, Parkinson’s disease, epilepsy, and additional neuronal disorders. However, the large-scale neuro-pharmacological actions of natural products have been familiar owing to the consequence of also the inhibition of inflammatory processes, or the up-regulation of various cell endurance proteins or a mixture of together. Owing to the shortage of human studies on neuroprotective belongings of natural products, this review highlights a variety of documented actions of natural products in vitro and in vivo preclinical models and their possible neuro-protection applications by the accessible awareness in writing.
Keywords: Anti-oxidant, natural product, Alzheimer's disease, neurodegeneration, biomarker, neurodegenerative diseases.
CNS & Neurological Disorders - Drug Targets
Title:Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
Volume: 20 Issue: 8
Author(s): Mohammad Habibur Rahman, Rokeya Akter and Mohammad Amjad Kamal*
Affiliation:
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, P.O. Box 80216,Saudi Arabia
Keywords: Anti-oxidant, natural product, Alzheimer's disease, neurodegeneration, biomarker, neurodegenerative diseases.
Abstract: Neurodegenerative diseases represent one of the most important public health problems and concerns, as they are a growing cause of mortality and morbidity worldwide, particularly in the elderly. However, natural products have a significant function in the avoidance of disease by boosting health in humans as well as animals. These natural products have been scientifically acknowledged to have a range of biological characteristics like antioxidant, and anti-inflammatory actions. Both In vitro and in vivo studies have more recognized the convenience of natural products in different preclinical models of neurodegenerative disorders. Moreover, most NPs comprise phytoconstituents, including polyphenolic antioxidants; originate in herbs, fruits, nuts, vegetables, as well as, also in marine with freshwater flora. These phytoconstituents might actively repress neuro-degeneration and recover memory as like cognitive actions of the brain. Moreover, they are well recognized to participate in an essential position in the prevention of like treatment of different neurodegenerative diseases, like Alzheimer’s disease, Parkinson’s disease, epilepsy, and additional neuronal disorders. However, the large-scale neuro-pharmacological actions of natural products have been familiar owing to the consequence of also the inhibition of inflammatory processes, or the up-regulation of various cell endurance proteins or a mixture of together. Owing to the shortage of human studies on neuroprotective belongings of natural products, this review highlights a variety of documented actions of natural products in vitro and in vivo preclinical models and their possible neuro-protection applications by the accessible awareness in writing.
Export Options
About this article
Cite this article as:
Rahman Habibur Mohammad, Akter Rokeya and Kamal Amjad Mohammad *, Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases, CNS & Neurological Disorders - Drug Targets 2021; 20 (8) . https://dx.doi.org/10.2174/1871527319666200722153611
DOI https://dx.doi.org/10.2174/1871527319666200722153611 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Lifestyle Interventions to Prevent and Treat Cognitive Impairment and Dementia
More than 55 million people live with dementia worldwide. By 2050, the population affected by dementia will exceed 139 million individuals. Mild cognitive impairment (MCI) is a pre-dementia stage, also known as prodromal dementia, affecting older adults. MCI emerges years before the manifestation of dementia but can be avoidable and ...read more
Novel Treatments in Subarachnoid Hemorrhage
The current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a ...read more
Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities
The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more
Role of glial cells in autism spectrum disorder: Molecular mechanism and therapeutic approaches
Emerging evidence suggests that glial cells may play a pivotal role in neuroanatomical and behavioral changes found in autism spectrum disorder (ASD). Many individuals with ASD experience a neuro-immune system abnormalities throughout life, which implicates a potential role of microglia in the pathogenesis of ASD. Dysfunctional astrocytes and oligodendrocytes were ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Engineered Liposomes for Drug Delivery and Biomedical Imaging
Recent Patents on Nanomedicine Delivery and Application of Dietary Polyphenols to Target Organs, Tissues and Intracellular Organelles
Current Drug Metabolism Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Prognostic Significance and Functional Mechanism of UTS2 in Glioblastoma Multiforme
Current Cancer Drug Targets A Discussion Regarding the Application of the Hertz Contact Theory on Biological Samples in AFM Nanoindentation Experiments
Micro and Nanosystems Chemotherapy with si-RNA and Anti-Cancer Drugs
Current Drug Delivery Peptide Targeted Copper-64 Radiopharmaceuticals
Current Topics in Medicinal Chemistry Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism Syntheses and Preliminary Evaluation of Dual Target PET Probe [<sup>18</sup>F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Current Medicinal Chemistry Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
Current Pharmaceutical Design The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry